v3.26.1
Consolidated Balance Sheets
¥ in Thousands, $ in Thousands
Dec. 31, 2025
CNY (¥)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
CNY (¥)
Current assets:      
Cash ¥ 50,332 $ 7,197 ¥ 18,604
Restricted cash 2 2
Short-term investments 1,560 223 1,433
Notes receivable, net 25,592
Accounts receivable, net 18,485 2,643 59,563
Advance to suppliers 2,208 316 10,788
Inventories, net 39,166 5,601 58,220
Prepayments and other current assets, net 25,667 3,670 2,626
Other receivable-a related party 738
Total current assets 137,420 19,650 177,566
Non-current assets:      
Property, plant and equipment, net 236,812 33,863 255,164
Land use rights, net 7,673 1,097 7,930
Intangible assets, net 47,084 6,732 14,850
Right-of-use assets, net 469 67
Long-term prepayments 7,014 1,003 18,698
Deferred IPO expenses 8,048
Net deferred tax assets 10,991
Total non-current assets 299,052 42,762 315,681
Total assets 436,472 62,412 493,247
Current liabilities:      
Short-term loans 65,100 9,309 74,443
Current maturities of long-term loans 700 100 7,190
Operating lease liability-current 106 15
Accounts payable 44,010 6,296 42,960
Contract liabilities 4,752 680 3,485
Taxes payable 2,345 335 2,066
Accrued expenses and other liabilities 3,463 495 5,617
Total current liabilities 120,476 17,230 135,907
Non-current liabilities:      
Long-term loans 8,850 1,266 4,800
Operating lease liability-non-current 327 47
Deferred tax liabilities 104 15
Total non-current liabilities 9,281 1,328 4,800
Total liabilities 129,757 18,558 140,707
Commitments and contingencies
Shareholders’ equity:      
Additional paid-in capital 240,752 34,427 203,150
Statutory reserves 32,647 4,668 32,647
Retained earnings (deficit) (21,633) (3,099) 48,151
Accumulated other comprehensive income (1,926) (275) 3
Total Zhengye Biotechnology Holding Limited’s shareholders’ equity 249,848 35,722 283,959
Noncontrolling interests 56,867 8,132 68,581
Total equity 306,715 43,854 352,540
Total liabilities and equity 436,472 62,412 493,247
Class A ordinary shares      
Shareholders’ equity:      
Ordinary shares, value [1] 1 1
Class B ordinary shares      
Shareholders’ equity:      
Ordinary shares, value [1] 7 1 7
Related Party      
Current liabilities:      
Amount due to related parties ¥ 146
[1] As of December 31, 2025, share reclassification was retroactively restated with effective date of March 24, 2026.